10 biventricular pacemakers from Medtronic gain FDA OK for wider use

04/11/2014 | Medscape (free registration)

Medtronic has secured expanded FDA approval for 10 of its biventricular pacemakers -- the Consulta CRT-P and CRT-D, Brava CRT-D, Syncra CRT-P, Concerto II CRT-D, Viva XT CRT-D and S CRT-D, Protecta CRT-D and XT CRT-D, and Maximo II CRT-D systems. The devices can now be used for patients with atrioventricular block requiring right-ventricular pacing, as well as those with moderate systolic heart failure.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC